Copyright: ©Author(s) 2026.
World J Gastroenterol. May 21, 2026; 32(19): 116513
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.116513
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.116513
Figure 1 Patient disposition chart.
PSM: Propensity score matching; MgIG: Magnesium isoglycyrrhizinate.
Figure 2 The proportion of patients with postoperative liver injury.
A: The proportion of patients with postoperative liver injury who received perioperative magnesium isoglycyrrhizinate vs those who received postoperative magnesium isoglycyrrhizinate only; B-D: Changes in serum alanine aminotransferase (ALT); E-G: Changes in serum aspartate aminotransferase (AST) levels. Postoperative liver injury is defined as ≥ 3 × upper limit of normal of the serum ALT or AST levels. Group number: A2-2 means prophylaxis group in which patients were treated with perioperative magnesium isoglycyrrhizinate plus postoperative other liver protectants; B2-2 means non-prophylaxis group in which patients were treated with postoperative magnesium isoglycyrrhizinate plus postoperative other liver protectants. aP < 0.05. bP < 0.01. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; POD: Postoperative day; NS: Not significant.
Figure 3 Analysis of prevalence of hepatic injury post hepatectomy.
A: Using generalized estimating equation; B-D: Changes in serum alanine aminotransferase and aspartate aminotransferase levels in the prophylaxis group (A0) vs the non-prophylaxis group (B0). aP < 0.05. cP < 0.001. POD: Postoperative day; CI: Confidence interval; OR: Odds ratio; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.
Figure 4 Changes in serum alanine aminotransferase and aspartate aminotransferase levels in the group (B2-2) upon treatment with magnesium isoglycyrrhizinate plus other liver protectants vs the control group (B2-3) upon treatment with other liver protectants.
A-H: The levels, changes from postoperative day 1, proportions of patients with ≥ 50% reduction in the serum levels of aminotransferase and the proportions of patients who had normalized serum alanine aminotransferase (A-D) and aspartate aminotransferase levels (E-H) post hepatectomy. aP < 0.05. cP < 0.001. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; POD: Postoperative day; NS: Not significant.
- Citation: Xie ZQ, Wei JX, Zhong JY, Luo X, Zhuang HK, Ma XW, Wang QB, Tan WL, Wang BK, Chen YJ, Li CJ, Shang CZ. Effectiveness of magnesium isoglycyrrhizinate on perioperative hepatic function protection in patients undergoing hepatectomy. World J Gastroenterol 2026; 32(19): 116513
- URL: https://www.wjgnet.com/1007-9327/full/v32/i19/116513.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i19.116513